LeadIQ logo
Learn more at LeadIQ.com
Aldeyra Therapeutics

Aldeyra Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Aldeyra Therapeutics discovers and develops innovative therapies designed to treat immune-mediated diseases. Our approach is to develop therapies that modulate immunological systems, instead of inhibiting or activating single targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Two of our lead product candidates, reproxalap and ADX-629, target pre-cytokine, systems-based mediators of inflammation known as RASP (reactive aldehyde species). Reproxalap is in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. ADX-629, an orally administered RASP modulator, is in Phase 2 proof-of-concept clinical trials in psoriasis, asthma, and COVID-19. Our pipeline also includes ADX-2191 (intravitreal methotrexate 0.8%), in development for the prevention of proliferative vitreoretinopathy and the treatment of retinitis pigmentosa and primary vitreoretinal lymphoma.

Find Aldeyra Therapeutics employees' phone numbers or email addresses

Aldeyra Therapeutics Global Highlights

Location
Employees

North America
32

Minus sign iconPlus sign icon
  • United States Of America
    32

Europe
1

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1

Aldeyra Therapeutics's Leadership

Contact profiles from Aldeyra Therapeutics

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Aldeyra Therapeutics known for?

Minus sign iconPlus sign icon
Aldeyra Therapeutics was founded in 2004 operates in the Biotechnology Research industry. The company's main headquarters is located in 131 Hartwell Avenue Suite 320 Lexington, Massachusetts 02421 US; you can contact the main corporate office by phone at . Explore Aldeyra Therapeutics's company overview page for more information.

What is Aldeyra Therapeutics's most common email format?

Minus sign iconPlus sign icon
Aldeyra Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Aldeyra Therapeutics email formats with LeadIQ.

How many employees does Aldeyra Therapeutics have currently?

Minus sign iconPlus sign icon
Aldeyra Therapeutics has approximately 17 employees as of November 2024. These team members are located across 2 continents, including North AmericaEurope.

Who are Aldeyra Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of November 2024, Aldeyra Therapeutics's key employees include:

  • Chief Executive Officer: T. B.
  • Chief Development Officer: S. G. M.
  • Chief Development Officer: S. G. M.
  • Vice President Quality Assurance: C. P.
  • Vice President Of Clinical Development: L. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.